MARMO J CHRISTOPHER 4
4 · OCULAR SCIENCES INC /DE/ · Filed Jan 7, 2005
Insider Transaction Report
Form 4
MARMO J CHRISTOPHER
Vice President
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2005-01-06$52.17/sh−6,001$313,072→ 0 totalExercise: $20.34Exp: 2011-10-01→ Common Stock (6,001 underlying) - Disposition to Issuer
Employee stock option (right to buy)
2005-01-06$59.51/sh−23,625$1,405,924→ 0 totalExercise: $13.00Exp: 2013-02-26→ Common Stock (23,625 underlying) - Disposition to Issuer
Employee stock option (right to buy)
2005-01-06$61.13/sh−8,000$489,040→ 0 totalExercise: $11.38Exp: 2010-08-18→ Common Stock (8,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2005-01-06$44.01/sh−20,000$880,200→ 0 totalExercise: $28.50Exp: 2014-02-23→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Pursuant to the Merger Agreement, this option, which provided for vesting in four equal annual installments beginning August 18, 2001, was accelerated and canceled in exchange for $136,061.15 and 2,399 shares of Cooper common stock, having a market value of $72.51 per share.
- [F2]Pursuant to the Merger Agreement this option, which provided for vesting in four equal annual installments beginning October 1, 2002, was accelerated and canceled in exchange for $78,451.12 and 1,383 shares of Cooper common stock, having a market value of $72.51 per share.
- [F3]Pursuant to the Merger Agreement, this option, which provided for vesting in four equal annual installments beginning February 26, 2004, was accelerated and canceled in exchange for $384,956.38 and 6,787 shares of Cooper common stock,having a market value of $72.51 per share.
- [F4]Pursuant to the Merger Agreement, this option, which provided for vesting in four equal annual installments beginning February 23, 2005, was accelerated and canceled in exchange for $189,833.57 and 3,347 shares of Cooper common stock, having a market value of $72.51 per share.
- [F5]This combination of cash and Cooper common stock represents the per share value of the merger consideration ($72.51 per share) minus the exercise price of the option, multiplied by the number of shares of issuer common stock subject to such option.